Molecular Cancer

Title Publication Date Language Citations
Advances in studies of tyrosine kinase inhibitors and their acquired resistance2018/02/19English226
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer2017/07/17English226
m6A-dependent glycolysis enhances colorectal cancer progression2020/04/03English225
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities2019/08/29English225
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer2018/09/27English223
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer2019/03/18English222
Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer2018/02/22English221
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments2022/03/18English220
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression2018/08/11English219
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy2020/04/27English218
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes2020/07/29English217
EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis2018/11/23English215
G-quadruplexes: a promising target for cancer therapy2021/02/25English215
Harnessing tumor-associated macrophages as aids for cancer immunotherapy2019/12/01English215
The relationship between autophagy and the immune system and its applications for tumor immunotherapy2019/01/24English215
Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex2006/06/28English214
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target2022/07/14English214
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation2016/01/06English214
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy2021/01/15English213
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies2017/07/06English212
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment2019/05/14English212
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities2020/11/24English211
RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner2020/05/19English210
PARP inhibitor resistance: the underlying mechanisms and clinical implications2020/06/20English210
Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression2019/07/19English210
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA2019/07/03English208
Circulating long non-coding RNAs in cancer: current status and future perspectives2016/05/17English208
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma2019/10/25English207
STING: a master regulator in the cancer-immunity cycle2019/11/04English207
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer2017/02/28English206